Skip Navigation U.S. Department of Health and Human Services www.hhs.gov/
Agency for Healthcare Research Quality www.ahrq.gov
www.ahrq.gov/

Treating Tobacco Use and Dependence: 2008 Update: Slide Presentation (Full)


Treatment Recommendations: Medications—Relative Effectiveness

Text Description is below the image.

Meta-analysis (2008): Effectiveness and abstinence rates of medications relative to the nicotine patch (n = 86 studies).

Medication Number of arms Estimated odds ratio (95% C. I.)
Nicotine Patch (reference group) 32 1.0
Combination therapies    
Patch (long-term; > 14 weeks) + NRT (gum or spray) 3 1.9 (1.3, 2.7)
Patch + Bupropion SR 3 1.3 (1.0, 1.8)
Patch + Nortriptyline 2 0.9 (0.6, 1.4)
Patch + Inhaler 2 1.1 (0.7, 1.9)
Second-generation antidepressants & Patch 3 1.0 (0.6, 1.7)
Medications not shown to be effective   0.8 (0.6, 1.0)
Selective Serotonin Reuptake Inhibitors (SSRIs) 3 0.5 (0.4, 0.7)
Naltrexone 2 0.3 (0.1, 0.6)

Next SlidePrevious Slide        Contents         Next Slide Next Slide


 

AHRQAdvancing Excellence in Health Care